4
Changes in Ownership
BIO-TECHNE Corp Filed Acc 0001437749-22-003021
Pres. Diagnostics & Genom acquired 1,989 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kelderman Kim Pres. Diagnostics & Genom | 2022-02-08 | Option exercise | +1,989 | $150.78 | $299,901 | 1,989 | D |
| Derivatives | |||||||
| Kelderman Kim Pres. Diagnostics & Genom | 2022-02-08 | Option exercise · Stock Option (Right to Buy) | −1,989 | 7,511 | D | ||
Loading xslF345X03/rdgdoc.xml…